Stem Cells

Index to this page
Related Pages
Culturing Human Embryonic Stem (ES) Cells
Making transgenic animals using embryonic stem cells
Cloning mammals using somatic cell nuclei

Stem cells are cells that divide to form

Several adjectives are used to describe the developmental potential of stem cells; that is, the number of different kinds of differentiated cell that they can become.
  1. Totipotent cells. In mammals, totipotent cells have the potential to become

    The only totipotent cells are the fertilized egg and the first 4 or so cells produced by its cleavage (as shown by the ability of mammals to produce identical twins, triplets, etc.).

    In mammals, the expression totipotent stem cells is a misnomer: these cells fail to meet the second criterion — they cannot make more of themselves.

  2. Pluripotent stem cells. These are true stem cells, with the potential to make any differentiated cell in the body, but cannot contribute to making the extraembryonic membranes (which are derived from the trophoblast).

    Three types of pluripotent stem cells have been found

    All three of these types of pluripotent stem cells


  3. Multipotent stem cells. These are true stem cells but can only differentiate into a limited number of types. For example, the bone marrow contains multipotent stem cells that give rise to all the cells of the blood but not to other types of cells. [Discussion]

    Multipotent stem cells are found in adult animals; perhaps most organs in the body (e.g., brain, liver) contain them where they can replace dead or damaged cells. These adult stem cells may also be the cells that — when one accumulates sufficient mutations — produce a clone of cancer cells.

Using Stem Cells for Human Therapy - The Dream

Many medical problems arise from damage to differentiated cells.

Examples:

The great developmental potential of stem cells has created intense research into enlisting them to aid in replacing the lost cells of such disorders.

While some success has been achieved with laboratory animals, not much has yet been achieved with humans.

One exception: culturing human epithelial stem cells and using their differentiated progeny to replace a damaged cornea. This works best when the stem cells are from the patient (e.g. from the other eye). Corneal cells from another person (an allograft) are always at risk of rejection by the recipient's immune system.

Using Stem Cells for Human Therapy - The Problems

So one major problem that must be solved before human stem cell therapy becomes a reality is the threat of rejection of the transplanted cells by the host's immune system (if the stem cells are allografts; that is, come from a genetically-different individual).
Link to discussions of

The Solution?

One way to avoid the problem of rejection is to use stem cells that are genetically identical to the host.

This is already possible in the rare situations when the patient has healthy stem cells in an undamaged part of the body (like the stem cells being used to replace damaged corneas).

But even where no "autologous" stems cells are available, there may be a solution: using somatic-cell nuclear transfer (but with no goal of attempting to implant the resulting blastocyst in a uterus).

In this technique,

While an exciting prospect, there are still problems with the method that must be solved.
Jose Cibelli and his team at Advanced Cell Technology report in the 1 February 2002 issue of Science that they have succeeded in
  • stimulating monkey oocytes to begin dividing without completing meiosis II (therefore still 2n)
  • growing these until the blastocyst stage, from which they were able to harvest
  • ES cells.
If this form of cloning by parthenogenesis works in humans, it would have
  • the advantage that no babies could be produced if the blastocyst should be implanted (two identical genomes cannot produce a viable mammal — probably because of incorrect imprinting);
  • the disadvantage that it will only help females (because only they can provide an oocyte!)

On 19 May 2005 Science published an online report that a group of Korean scientists (such government-funded work is currently forbidden in the US) have created human ES cells from blastocysts produced following somatic cell nuclear transfer (SCNT). In each case, the donor nucleus came from a skin cell of a person who was not related to the woman who provided the enucleated egg.

When injected into SCID mice, these cells formed teratomas; tumors containing a mix of differentiated human cell types, including cells characteristic of ectoderm, mesoderm, and endoderm.

Welcome&Next Search

22 November 2005